• REGISTER NOW for a Webinar on Nov 1st, 2017
    12:00 noon EDT

    The Evolving Role of Invasive and Non-Invasive Assessment Tools in Liver Disease

    Educational program from CLDF, sponsored by Echosens North America

    Register here
  • Learn more about the utility of FibroScan® from the experts.

    Visit our Video Library for more Webinars and Videos.

    Video Library
  • Echosens
    North America
    is your innovation partner
    for non-invasive liver
    disease diagnostics

    Learn More
  • The industry standard
    for the non-invasive
    assessment of
    liver diseases.

    Learn More
  • Dual Function
    Liver Diagnostics
    VCTE and CAP
    State-of-the-art of non-invasive
    liver diagnostics

    Learn More
  • Engineered with
    Smart Tools to support
    consistency, irrespective of
    operator and across most
    patient morphologies.

    Learn More

Innovation in Liver Disease Management
Using patented Vibration Controlled Transient Elastography (VCTE), the FibroScan® 502 Touch is the first noninvasive device indicated for use as an aid in the clinical management of patients with liver disease.

Learn More →

Enhancing access through mobility
The FibroScan® 530 Compact offers the same dual function capabilities and examination experience as the FibroScan® 502 Touch.

Learn More →

In North America, there are more than 350 FibroScan® systems. We’re growing fast!

Check out our map →

Echosens is now your direct partner in the United States.

Contact Us

Video Library

Left VIdeo: 

Webinar: FibroScan Threshold Value Update

Right Video: 

Webinar: The Role of Elastography in Chronic Liver Disease: The AGA Guidelines


Using patented VCTE and CAP, FibroScan® is the first totally non-invasive device indicated for use as an aid in the clinical management of patients with liver disease. The examination with FibroScan® is rapid and easily repeatable over time. This unique, accurate and efficient device brings extra confidence to patient management.